SCHEMBL3888568

SCHEMBL3888568

CCN(CC)C(CCC(C)N)c1c2ccccc2nc2ccc(Br)cc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RXFP1 Q9HBX9 2/20 0.37
▸ DPP4 P27487 1/20 0.37
▸ CACNA2D1 P54289 4/20 0.35
▸ HDAC3 O15379 1/20 0.35
▸ APP P05067 1/20 0.35
▸ ACHE P22303 1/20 0.35
▸ HDAC4 P56524 1/20 0.35
▸ HDAC1 Q13547 1/20 0.35
▸ HDAC7 Q8WUI4 1/20 0.35
▸ HDAC2 Q92769 1/20 0.35
▸ HDAC10 Q969S8 1/20 0.35
▸ HDAC11 Q96DB2 1/20 0.35
▸ HDAC8 Q9BY41 1/20 0.35
▸ HDAC6 Q9UBN7 1/20 0.35
▸ HDAC9 Q9UKV0 1/20 0.35
▸ HDAC5 Q9UQL6 1/20 0.35
▸ NCOR2 Q9Y618 1/20 0.35
▸ ALDH1A1 P00352 3/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3887726 0.89 CACNA2D1 (0.41) CACNA2D1ACHEALDH1A1KDM4EGAA
SCHEMBL4777085 0.76 CACNA2D1 (0.40) CACNA2D1ACHEALDH1A1KDM4EGAA
SCHEMBL17799171 0.72 USP2 (0.52) APPACHEALDH1A1KDM4EGAA
SCHEMBL3875260 0.66 KDM4E (0.41) CACNA2D1APPACHEALDH1A1KDM4E
SCHEMBL5471094 0.65 CACNA2D1 (0.80) CACNA2D1APPACHEALDH1A1KDM4E
SCHEMBL8288054 0.65 CACNA2D1 (0.80) CACNA2D1APPACHEALDH1A1KDM4E
SCHEMBL5468037 0.65 CACNA2D1 (0.80) CACNA2D1APPACHEALDH1A1KDM4E
SCHEMBL30981743 0.64 PRNP (0.47) RXFP1HDAC3APPACHEHDAC4
SCHEMBL13696895 0.64 ACHE (0.67) HDAC3APPACHEHDAC4HDAC1
SCHEMBL4777093 0.63 CACNA2D1 (0.52) CACNA2D1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1687275-A4 PYRIDIN-4-YLAMINE COMPOUNDS USEFUL IN THE TREATMENT OF NEUROPATHIC PAIN MERCK & CO INC (US) 2009-01-14 — — EP disclosed
EP-1687275-A1 PYRIDIN-4-YLAMINE COMPOUNDS USEFUL IN THE TREATMENT OF NEUROPATHIC PAIN Merck & Co., Inc. (US) 2006-08-09 — — EP disclosed
WO-2005051915-A1 PYRIDIN-4-YLAMINE COMPOUNDS USEFUL IN THE TREATMENT OF NEUROPATHIC PAIN MERCK & CO., INC. (US) 2005-06-09 — — WO disclosed
Send feedback